These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE. Nature; 1993 Apr 22; 362(6422):749-51. PubMed ID: 8097018 [Abstract] [Full Text] [Related]
6. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Prawitt D, Enklaar T, Gärtner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, Zabel B. Proc Natl Acad Sci U S A; 2005 Mar 15; 102(11):4085-90. PubMed ID: 15743916 [Abstract] [Full Text] [Related]
7. Excess functional copy of allele at chromosomal region 11p15 may cause Wiedemann-Beckwith (EMG) syndrome. Kubota T, Saitoh S, Matsumoto T, Narahara K, Fukushima Y, Jinno Y, Niikawa N. Am J Med Genet; 1994 Feb 15; 49(4):378-83. PubMed ID: 7909196 [Abstract] [Full Text] [Related]
8. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK. Nature; 1988 Nov 24; 336(6197):374-6. PubMed ID: 2848199 [Abstract] [Full Text] [Related]
10. Molecular biology of Beckwith-Wiedemann syndrome. Weksberg R, Squire JA. Med Pediatr Oncol; 1996 Nov 24; 27(5):462-9. PubMed ID: 8827075 [Abstract] [Full Text] [Related]
11. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B. Mol Cancer Res; 2005 Sep 24; 3(9):493-502. PubMed ID: 16179496 [Abstract] [Full Text] [Related]
14. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5. Overall ML, Spencer J, Bakker M, Dziadek M, Smith PJ. Genes Chromosomes Cancer; 1996 Sep 24; 17(1):56-9. PubMed ID: 8889507 [Abstract] [Full Text] [Related]
15. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity. Ohlsson R, Cui H, He L, Pfeifer S, Malmikumpu H, Jiang S, Feinberg AP, Hedborg F. Cancer Res; 1999 Aug 15; 59(16):3889-92. PubMed ID: 10463576 [Abstract] [Full Text] [Related]
16. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization. Altura RA, Valentine M, Li H, Boyett JM, Shearer P, Grundy P, Shapiro DN, Look AT. Cancer Res; 1996 Aug 15; 56(16):3837-41. PubMed ID: 8706032 [Abstract] [Full Text] [Related]
17. Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours. Satoh Y, Nakadate H, Nakagawachi T, Higashimoto K, Joh K, Masaki Z, Uozumi J, Kaneko Y, Mukai T, Soejima H. Br J Cancer; 2006 Aug 21; 95(4):541-7. PubMed ID: 16909133 [Abstract] [Full Text] [Related]
18. Duplication of HRAS1, INS, and IGF2 is not a common event in Beckwith-Wiedemann syndrome. Henry I, Jeanpierre M, Barichard F, Serre JL, Mallet J, Turleau C, de Grouchy J, Junien C. Ann Genet; 1988 Aug 21; 31(4):216-20. PubMed ID: 2905880 [Abstract] [Full Text] [Related]
19. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour. Cerrato F, Sparago A, Verde G, De Crescenzo A, Citro V, Cubellis MV, Rinaldi MM, Boccuto L, Neri G, Magnani C, D'Angelo P, Collini P, Perotti D, Sebastio G, Maher ER, Riccio A. Hum Mol Genet; 2008 May 15; 17(10):1427-35. PubMed ID: 18245780 [Abstract] [Full Text] [Related]
20. Molecular and cellular biology of Wilms' tumour. Maitland NJ, Brown KW, Poirier V, Shaw AP, Williams J. Anticancer Res; 1989 May 15; 9(5):1417-26. PubMed ID: 2556071 [Abstract] [Full Text] [Related] Page: [Next] [New Search]